Royalty Pharma PLC (Class A)
Closed
SectorHealthcare
57.78 3.64
Overview
Share price change
24h
Min
55.52
Max
57.78
Income | -61M 295M |
|---|---|
Sales | 8.6M 631M |
P/E Sector Avg | 30.047 56.269 |
EPS | 1.3 |
Dividend yield | 1.59 |
Profit margin | 46.733 |
Employees | 100 |
EBITDA | 112M 563M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +5.99% upside |
Dividend yield Sector Avg | 1.59% 2.29% |
|---|---|
Next Earnings | 5 sie 2026 |
Next Dividend date | 9 wrz 2026 |
Next Ex Dividend date | 14 sie 2026 |
Market Cap | 3.1B 33B |
|---|---|
Previous open | 54.14 |
Previous close | 57.78 |
News Sentiment
By Acuity
50%
50%
140 / 342 Ranking in Healthcare
Royalty Pharma PLC (Class A) Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Royalty Pharma PLC (Class A) Forecast
Price Target
By TipRanks
12 Months Forecast
Average 59.43 USD 5.99%
High 66 USD
Low 50 USD
Based on 7 Wall Street analysts offering 12 month price targets forRoyalty Pharma PLC (Class A) - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$